| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $437K | +105.6% |
| Cost of Revenue | $202K | +4.3% |
| Gross Profit | $236K | +1128.6% |
| R&D Expense | $330K | -55.9% |
| SG&A Expense | $8.1M | +30.6% |
| Operating Income | -$9.2M | -19.3% |
| Interest Expense | $22K | -95.2% |
| Pre-tax Income | -$9.0M | -4.0% |
| Income Tax | $0 | — |
| Net Income | -$9.0M | -4.0% |
| EPS (Diluted) | $6.12 | +103.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $36K | +46.8% |
| Inventory | $147K | -34.8% |
| Current Assets | $5.2M | -41.0% |
| Total Assets | $6.6M | -40.7% |
| Current Liabilities | $1.7M | +32.8% |
| Total Liabilities | $1.7M | +23.9% |
| Stockholders' Equity | $5.0M | -49.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -6.7% |
| Capital Expenditures | $38K | — |
| Investing Cash Flow | -$38K | — |
| Financing Cash Flow | $3.4M | -72.2% |
| Free Cash Flow | -$7.0M | -7.3% |